- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma.
August 17, 2020
Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients.
August 17, 2020
Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma.
August 17, 2020
Contribution and Expression of Organic Cation Transporters and Aquaporin Water Channels in Renal Cancer.
August 14, 2020
MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features.
August 14, 2020
Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
August 13, 2020
Triggers for delayed intervention in patients with small renal masses undergoing active surveillance: a systematic review.
August 12, 2020
Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging.
August 12, 2020
Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes.
August 12, 2020
LncRNA MEG3 mediates renal cell cancer progression by regulating ST3Gal1 transcription and EGFR sialylation.
August 11, 2020
Fumarate hydratase as a therapeutic target in renal cancer.
August 11, 2020
Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma.
August 11, 2020
The immunology of renal cell carcinoma.
August 10, 2020